Improving quality of bacterial culture and oligonucleotides with UV/Vis spectroscopy to accelerate mRNA vaccine production

mRNA vaccines are a new type of vaccine against infectious diseases. Traditionally, vaccines use a weakened or inactivated form of a pathogen to trigger an immune response. mRNA vaccines, however, enable cells to synthesize a protein that triggers a potent immune response against infectious disease. Manufacturing mRNA vaccines is a complex process that requires highly […]

Read More →